Arterra Bioscience SpA MIL:ARBS:
9M REVENUE EUR 3.6 MILLION
Arterra Bioscience 9M Revenue EUR 3.6 Mln
Earlier from Arterra Bioscience Spa
- ARBS: H1 2025 saw 35.5% revenue growth, 143% EBITDA increase, and robust net profit margin
- ARBS: Revenue up 12.8% year-over-year to €2.6M, led by strong cosmetic raw material sales growth
- ARBS: Q1 2025 revenue rose 21.6% year-over-year to €1.3 million, led by cosmetic raw material sales
- ARBS: Strong profit growth and R&D advances support a positive outlook and dividend proposal